封面
市場調查報告書
商品編碼
1736702

全球整形外科植入市場規模(按植入類型、應用、終端用戶、區域範圍和預測)

Global Orthopedic Implants Market Size By Kind Of Implant, By Application, By Final User (Hospitals, Ambulatory Surgical Centers Orthopedic Clinics), By Geographic Scope And Forecast

出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

整形外科植入市場規模及預測

2024 年整形外科植入市場規模價值為 495.1 億美元,預計到 2032 年將達到 700.9 億美元,2026 年至 2032 年的複合年成長率為 4.90%。

整形外科植入是用於修復或支撐骨折和關節的醫療設備。螺絲、鋼板、棒和人工關節用於輔助癒合過程並恢復功能。整形外科植入常用於關節置換、骨折矯正和脊椎固定等手術。

它們的應用範圍廣泛,包括創傷、退化性疾病和先天性疾病,確保不同患者群體成功治療。材料科學和生物技術的進步預示著整形外科植入前景光明。

3D列印植入和適應生理變化的智慧材料等創新治療方法有望改善治療效果,為更個人化的醫療和更好的患者照護鋪平道路。

全球整形外科植入市場動態

影響全球整形外科植入市場的關鍵市場動態是:

關鍵市場促進因素

骨關節炎和肌肉骨骼疾病盛行率不斷上升:全球範圍內,骨關節炎和其他肌肉骨骼疾病的發生率正在上升,這主要是由於人口老化和肥胖率上升。這一趨勢增加了對整形外科手術的需求,尤其是髖關節和膝關節手術等關節關節重建手術。隨著醫療保健系統響應這項需求,整形外科植入製造商正在優先考慮創造性解決方案,以改善患者的治療效果。例如,世界衛生組織 (WHO) 在 2023 年 3 月報告稱,關節相關疾病的發生率急劇上升,這促使整形外科醫療保健支出增加。

植入設計和材料的技術進步:整形外科植入技術的創新,例如微創手術技術和先進生物材料的開發,正在顯著推動市場成長。近期的進展使得植入具有更好的生物相容性、更快的恢復時間和更高的整體性能。 2023年1月,史賽克公司推出了一系列採用增強材質設計的全新整形外科植入,以提高強度和耐用性,彰顯了市場對技術進步的關注。

政府措施與投資:近期政府為改善醫療基礎設施而推出的措施正在推動整形外科植入業務的發展。例如,美國衛生與公眾服務部於2023年6月宣布了一項500萬美元的計劃,用於支持整形外科技術研究並促進創新。這項資金旨在促進創新並改善治療方案,從而鼓勵更多公司投資整形外科領域。

運動醫學需求日益成長:隨著越來越多的人參與運動和健身,運動相關傷害的數量也在增加,這推動了對整形外科植入的需求。各公司正在開發專門用於治療運動傷害的植入和器械,從而推動該領域的市場成長。全錄輝公司於2023年8月宣布將擴大其運動醫學產品系列,彰顯其對這一快速成長領域的投入。

主要問題

植入和手術費用高昂:整形外科植入和手術費用昂貴,限制了病患(尤其是在較貧窮的國家)的就醫機會。這種經濟障礙可能會阻礙市場擴張,因為醫療保健系統和患者可能會尋求替代療法,甚至完全放棄重要的治療方案。

嚴格的監管要求:整形外科植入市場受到嚴格監管,以確保病患安全和產品有效性。滿足這些嚴格的標準對公司而言可能既耗時又昂貴,這可能導致產品發布延遲,並產生高昂的開發成本,進而影響盈利。

來自替代療法的競爭:整形外科植入產業面臨物理療法、藥物療法和生物療法等非侵入性療法的競爭。隨著患者尋求侵入性較小的治療方案來緩解疼痛和改善行動能力,對外科植入的需求可能會下降,迫使製造商調整策略。

併發症和植入失敗:患者可能會因為感染疾病、植入失敗、不良反應等風險而避免接受整形外科手術。這些風險要求植入設計和材料不斷進步,這增加了製造商的開發負擔,同時也影響了患者的信心和對整形外科治療的接受度。

主要趨勢

植入和手術費用高昂:整形外科植入和手術治療費用昂貴,限制了患者獲得治療的機會,尤其是在較貧窮的國家。此類經濟障礙可能會阻礙市場擴張,因為醫療保健系統和患者可能會尋求替代藥物,甚至完全放棄重要的治療。

嚴格的監管要求:整形外科植入市場受到嚴格監管,以確保病患安全和產品有效性。滿足這些嚴格的標準對公司而言可能既耗時又昂貴,這可能導致產品發布延遲,並產生高昂的開發成本,進而影響盈利。

來自替代療法的競爭:整形外科植入產業面臨物理療法、藥物療法和生物療法等非侵入性療法的競爭。隨著患者尋求侵入性較小的治療方案來緩解疼痛和改善行動能力,對外科植入的需求可能會下降,迫使製造商調整策略。

併發症和植入失敗:患者可能會因為感染疾病、植入失敗、不良反應等風險而避免接受整形外科手術。這些風險要求植入設計和材料不斷進步,這增加了製造商的開發負擔,同時影響了患者的信心和對整形外科治療的採用。

目錄

第1章全球整形外科植入市場介紹

  • 市場概覽
  • 研究範圍
  • 先決條件

第2章執行摘要

第3章:已驗證的市場研究調查方法

  • 資料探勘
  • 驗證
  • 第一手資料
  • 資料來源列表

第4章全球整形外科植入市場展望

  • 概述
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 波特五力模型
  • 價值鏈分析

第5章全球整形外科植入市場(植入類型)

  • 概述
  • 短人工關節
  • 脊椎移植

第6章全球整形外科植入市場(按應用)

  • 概述
  • 髖關節植入
  • 膝關節植入
  • 脊椎移植
  • 肩關節關節移植

第7章全球整形外科植入市場(按終端用戶)

  • 概述
  • 醫院
  • 門診手術中心(ASC)
  • 整形外科診所

第8章全球整形外科植入市場(按地區)

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 其他
    • 拉丁美洲
    • 中東

第9章全球整形外科植入市場競爭格局

  • 概述
  • 各公司市場排名
  • 重點發展策略

第10章 公司簡介

  • Johnson & Johnson Services Inc.
  • Zimmer Biomet
  • Stryker Corporation
  • Medtronic plc
  • Smith & Nephew plc
  • Exactech, Inc.
  • B. Braun Melsungen AG.

第11章 附錄

  • 相關調查
簡介目錄
Product Code: 40163

Orthopedic Implants Market Size And Forecast

Orthopedic Implants Market size was valued at USD 49.51 Billion in 2024 and is projected to reach USD 70.09 Billion by 2032, growing at a CAGR of 4.90% from 2026 to 2032.

Orthopedic implants are medical devices that repair or support broken bones and joints. Screws, plates, rods, and prosthetic joints are used to aid in the healing process and restore function. Orthopedic implants are commonly used in surgeries to replace joints, correct fractures, and stabilize the spine.

Their applications cover a wide range of ailments, including trauma, degenerative diseases, and congenital problems, ensuring successful therapy for a diverse patient population. Advancements in materials science and biotechnology point to a hopeful future for orthopedic implants.

Innovations like 3D-printed implants and smart materials that adapt to physiological changes are expected to improve treatment outcomes, paving the path for more personalized medicine and better patient care.

Global Orthopedic Implants Market Dynamics

The key market dynamics that are shaping the global orthopedic implants market include:

Key Market Drivers:

Increasing Prevalence of Osteoarthritis and Musculoskeletal Disorders: The frequency of osteoarthritis and other musculoskeletal problems is increasing worldwide, owing mostly to an ageing population and rising obesity rates. This tendency drives up demand for orthopedic procedures, notably joint replacements such as hip and knee surgery. As healthcare systems respond to this need, orthopedic implant makers prioritize creative solutions to improve patient outcomes. For example, in March 2023, the World Health Organization reported a surge in joint-related disorders, driving additional expenditure in orthopedic healthcare.

Technological Advancements in Implant Design and Materials: Innovations in orthopedic implant technology, including the development of minimally invasive surgical techniques and advanced biomaterials, are significantly driving market growth. Recent advancements have led to implants that offer better biocompatibility, reduced recovery times, and improved overall performance. In January 2023, Stryker Corporation launched a new range of orthopedic implants designed with enhanced materials that provide greater strength and durability, showcasing the market's focus on technological progress.

Governmental Initiatives and Investments: Recent government initiatives to improve healthcare infrastructure have boosted the orthopedic implants business. For example, in June 2023, the United States Department of Health and Human Services announced a $5 million project to support orthopedic technology research, thereby fostering innovation. This funding aims to foster innovation and improve treatment options, encouraging more companies to invest in the orthopedic sector.

Rising Need For Sports Medicine: As more people participate in sports and fitness activities, the number of sports-related injuries rises, driving up demand for orthopedic implants. Companies are reacting by creating specific implants and gadgets for treating sports injuries, hence boosting market growth in this area. Smith & Nephew announced the expansion of its sports medicine product portfolio in August 2023, demonstrating its commitment to serving this burgeoning sector.

Key Challenges:

High Costs of Implants and Procedures: Orthopedic implants and surgical treatments can be costly, limiting access for patients, especially in poor nations. This financial barrier might stymie market expansion, as healthcare systems and patients may seek alternatives or forego critical treatments entirely.

Strict Regulatory Requirements: The orthopedic implants market is closely regulated to ensure patient safety and product efficacy. Meeting these strict criteria can be time-consuming and expensive for businesses, potentially delaying product releases and raising development expenses, affecting profitability.

Competition from Alternative Treatments: The orthopedic implants industry faces competition from non-invasive treatments like physiotherapy, medicine, and biologic therapies. As patients seek less intrusive options for pain management and mobility concerns, demand for surgical implants may decline, forcing manufacturers to adjust their strategy.

Complications and Implant Failures: Patients may avoid orthopedic operations due to risks such as infections, implant failures, and bad reactions. These hazards need ongoing advancements in implant design and materials, which increases the development load for manufacturers while also influencing patient trust and adoption of orthopedic treatments.

Key Trends:

High Costs of Implants and Procedures: Orthopedic implants and surgical treatments can be costly, limiting access for patients, especially in poor nations. This financial barrier might stymie market expansion, as healthcare systems and patients may seek alternatives or forego critical treatments entirely.

Strict Regulatory Requirements: The orthopedic implants market is closely regulated to ensure patient safety and product efficacy. Meeting these strict criteria can be time-consuming and expensive for businesses, potentially delaying product releases and raising development expenses, affecting profitability.

Competition from Alternative Treatments: The orthopedic implants industry faces competition from non-invasive treatments like physiotherapy, medicine, and biologic therapies. As patients seek less intrusive options for pain management and mobility concerns, demand for surgical implants may decline, forcing manufacturers to adjust their strategy.

Complications and Implant Failures: Patients may avoid orthopedic operations due to risks such as infections, implant failures, and bad reactions. These hazards need ongoing advancements in implant design and materials, which increases the development load for manufacturers while also influencing patient trust and adoption of orthopedic treatments.

Global Orthopedic Implants Market Regional Analysis

Here is a more detailed regional analysis of the global orthopedic implants market:

North America:

North America dominates the orthopedic implants market, owing to improved healthcare infrastructure, large healthcare expenditures, and an aging population. The region's well-established medical device industry, combined with large investments in R&D, allows for the speedy introduction of breakthrough devices. Furthermore, the frequency of musculoskeletal problems, particularly among the elderly, drives up demand for orthopedic treatments such joint replacements. Medtronic announced a $50 million investment in August 2023 to enhance its orthopedic product offerings, demonstrating its commitment to meeting the demands of this increasing patient population.

Furthermore, supportive government initiatives and regulatory frameworks improve the market environment in North America. The United States Food and Drug Administration (FDA) has shortened approval processes for orthopedic implants, allowing new technologies to enter the market more quickly. In July 2023, the FDA announced a new initiative to expedite the clearance of innovative orthopedic devices, which is projected to drive further growth in this industry. As a result, the combination of technological breakthroughs, strong healthcare systems, and supportive regulatory frameworks places North America as a market leader for orthopedic implants.

Asia Pacific:

The Asia Pacific area is emerging as the fastest-growing market for orthopedic implants, owing to rising industrialization, urbanization, and increased healthcare investments. The burgeoning middle-class population in nations such as China and India is driving up disposable incomes, increasing demand for modern healthcare services such as orthopedic procedures. Furthermore, the rising frequency of osteoarthritis and sports-related injuries is increasing the demand for orthopedic implants. In May 2023, the Indian government proposed a $3 billion investment in healthcare infrastructure, which is likely to increase access to orthopedic care and, as a result, demand for implants.

Furthermore, the Asia Pacific market is seeing substantial improvements in manufacturing technologies, including as 3D printing and novel materials, which are increasing the availability and customisation of orthopedic implants. Companies are increasingly turning to local manufacturing to cut costs and increase supply chain efficiency. Stryker Corporation, for example, will open a new factory in Singapore in September 2023 to manufacture sophisticated orthopedic implants specifically for the regional market. This relocation underscores not only rising demand, but also the strategic importance of the Asia Pacific area in the worldwide orthopedic implants landscape.

Global Orthopedic Implants Market: Segmentation Analysis

The Global Orthopedic Implants Market is segmented on the basis of By Kind Of Implants, By Application, By Final User and By Geography.

Orthopedic Implants Market, By Kind of Implants

  • Short Joint Replacements
  • Spinal Implants

Based on Kind Of Implants, the Global Orthopedic Implants Market is segmented into Short Joint Replacements, Spinal Implants. The short joint replacements segment is the dominant category in the global orthopedic implants market, primarily due to the high prevalence of conditions like osteoarthritis and the increasing number of joint replacement surgeries. This segment benefits from advancements in implant technology and materials, leading to improved patient outcomes and higher adoption rates among healthcare providers. The spinal implants segment is the fastest growing segment in the orthopedic implants market, driven by the rising incidence of spinal disorders and an aging population.

Orthopedic Implants Market, By Application

  • Hip Implants
  • Knee Implants
  • Spine implants
  • Shoulder Implants

Based on Application, the Global Orthopedic Implants Market is segmented into Hip Implants, Knee Implants, Spine implants, Shoulder Implants. The knee implants segment is the dominant category in the global orthopedic implants market, largely due to the high incidence of knee-related conditions such as osteoarthritis. The increasing number of knee replacement surgeries, supported by advancements in implant technology and materials, drives substantial market demand. The spine implants segment is the fastest growing segment in the orthopedic implants market, fueled by the rising prevalence of spinal disorders and injuries. Innovations in spinal surgery techniques and the development of advanced spinal devices are enhancing treatment options and driving rapid growth in this area.

Orthopedic Implants Market, By Final User

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Orthopedic Clinics

Based on Final User, the Global Orthopedic Implants Market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Orthopedic Clinics. The hospitals segment is the dominant category in the global orthopedic implants market, primarily due to the high volume of surgical procedures performed in these facilities. The ambulatory surgical centers (ASCs) segment is the fastest growing segment in the orthopedic implants market, driven by the increasing preference for outpatient procedures. ASCs offer cost-effective solutions, shorter recovery times, and improved patient convenience, leading to a rise in orthopedic surgeries performed in these settings.

Orthopedic Implants Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on the Geography, the Global Orthopedic Implants Market are classified into North America, Europe, Asia Pacific, Rest of the World. North America is the dominant region, owing to its advanced industrial infrastructure and widespread use of precision measurement technologies across industries. The Asia Pacific region is the fastest growing, thanks to rapid industrialization, expanding manufacturing capabilities, and rising investments in technology and infrastructure in emerging economies such as China and India.

Key Players

The "Global Orthopedic Implants Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Johnson & Johnson Services Inc., Zimmer Biomet, Stryker Corporation, Medtronic plc, Smith & Nephew plc, Exactech, Inc. and B. Braun Melsungen AG.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

  • Orthopedic Implants Market Recent Developments
  • In July 2023, Zimmer Biomet introduced the Persona IQ knee implant, a smart orthopedic device with inbuilt sensors that provide real-time information about patient healing. This discovery marks a huge step forward in individualized orthopedic therapy, allowing for improved monitoring and customization of rehabilitation methods.
  • In August 2023, Medtronic has expanded its orthopedic product portfolio with the introduction of a new generation of sophisticated spinal implants intended to improve patient outcomes. These implants incorporate cutting-edge technology targeted at improving stability and reducing recovery times, demonstrating the company's dedication to meeting the demands of spine surgery patients.
  • In September 2023, Stryker launched a new manufacturing facility in Singapore to produce orthopedic implants, mainly knee and hip replacements. This facility intends to strengthen local supply chains and the availability of sophisticated orthopedic treatments in the Asia Pacific area, in response to rising demand for surgical implants.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL ORTHOPEDIC IMPLANTS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL ORTHOPEDIC IMPLANTS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY KIND OF IMPLANTS

  • 5.1 Overview
  • 5.2 Short Joint Replacements
  • 5.3 Spinal Implants

6 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Hip Implants
  • 6.3 Knee Implants
  • 6.4 Spine implants
  • 6.5 Shoulder Implants

7 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY FINAL USER

  • 7.1 Overview
  • 7.2 Hospitals
  • 7.3 Ambulatory Surgical Centers (ASCs)
  • 7.4 Orthopedic Clinics

8 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East

9 GLOBAL ORTHOPEDIC IMPLANTS MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Johnson & Johnson Services Inc.
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Zimmer Biomet
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Stryker Corporation
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Medtronic plc
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Smith & Nephew plc
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Exactech, Inc.
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 B. Braun Melsungen AG.
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments

11 Appendix

  • 11.1 Related Research